Wesfarmers makes a move

Wesfarmers has bought nearly 20% of API, in the latest move in the war to acquire the wholesaler On Thursday Wesfarmers made the announcement that it has acquired 95.1 million shares in Australian Pharmaceutical Industries Limited—representing 19.3% of API’s shares outstanding. “The acquisition was made pursuant to the Undertaking Agreement entered into on 9 July